Enquiry Now
Loading...
| A00768 | Pages: NA | Aug 2021 | 3701 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the World Patient Engagement Solutions Market
Request Now !Patient engagement refers to anything that enables healthcare institutions to establish communication with their patients to using patient portal online. However, patient engagement is not just about engaging technology such as portal as well as automated messaging. Besides this, the process plays a vital role in ensuring patient satisfaction. On the other hand, the technology improves the service quality and ensures safety.
There are many drivers, restraints and opportunities that are influencing the patient engagement solutions market. Increasing awareness about mobile health, growing aging population as well as incentives provided by the government are responsible for driving the patient engagement market. However, absence of health literacy has hampered the market growth to a greater extent. Moreover, demand for value based drugs due to an increase in peer pressure and dramatic shift in patient specific solution would create greater opportunities.
The market is segmented based on components, delivery model, therapeutics, end-customer and geography. The key components assessed in the study includes hardware, software, consulting services and many more. Delivery model covered during the study are on premise, cloud and web. Therapeutics areas discussed in the report consists of fitness, diabetes, women health, obesity etc. Major end-customers of the market are payers, providers, patients and more. Regions such as North America, Europe, Asia -Pacific and LAMEA would experience rapid growth.
A closer look at the competitive landscape reveals that major IT brands are busy launching patient engagement solutions and generating clients in the same month itself. Prominent market players are also seen acquiring new companies or local market players to maintain their competitive edge. Other business strategies favored by the companies include constant upgradation, joint ventures and collaborations. Prominent brands active in the market are Orion Health, Emmi Solutions LLC., Allscripts Inc., Medecision Inc., Athenahealth, Inc. and others.
KEY BENEFITS FOR STAKEHOLDERS
1. INTRODUCTION
1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tool & model
2. EXECUTIVE SUMMARY
2.1. CXO perspective
3. MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top factors impacting the market
3.2.2. Top investment pockets
3.2.3. Top winning strategies
3.3. Regulatory initiatives
3.4. Porter’s five force analysis
3.5. Market player positioning
3.6. Market dynamics
3.6.1. Drivers
3.6.2. Restraints
3.6.3. Opportunities
4. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2017-2024 ($MILLION)
4.1. Market overview
4.2. Hardware
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.3. Software
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.4. Services
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
5. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017-2024 ($MILLION)
5.1. Market overview
5.2. On-premise
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.3. Cloud
5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
6. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2017-2024 ($MILLION)
6.1. Market overview
6.2. Hospitals and healthcare providers
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.3. Healthcare payers
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.4. Individual users
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.5. Others
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
7. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
7.1. Market overview
7.2. Health management
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.3. Home health management
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.4. Financial health management
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.5. Social and behavioral management
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.6. Others
7.6.1. Key market trends
7.6.2. Key growth factors and opportunities
7.6.3. Market size and forecast
8. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2017-2024 ($MILLION)
8.1. Market overview
8.2. Chronic diseases
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
8.3. Women’s health
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.4. Fitness
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.5. Others
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
9. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2017-2024 ($MILLION)
9.1. Market overview
9.2. North America
9.2.1. Key market trends
9.2.2. Key growth factors and opportunities
9.2.3. Market size and forecast by
9.2.3.1. Component
9.2.3.2. Deployment mode
9.2.3.3. End user
9.2.3.4. Application
9.2.3.5. Therapeutic area
9.2.3.6. Country
9.2.3.6.1. U.S.
9.2.3.6.1.1. Market size and forecast, by component
9.2.3.6.1.2. Market size and forecast, by deployment mode
9.2.3.6.1.3. Market size and forecast, by end user
9.2.3.6.1.4. Market size and forecast, by application
9.2.3.6.1.5. Market size and forecast, by therapeutic area
9.2.3.6.2. Canada
9.2.3.6.2.1. Market size and forecast, by component
9.2.3.6.2.2. Market size and forecast, by deployment mode
9.2.3.6.2.3. Market size and forecast, by end user
9.2.3.6.2.4. Market size and forecast, by application
9.2.3.6.2.5. Market size and forecast, by therapeutic area
9.2.3.6.3. Mexico
9.2.3.6.3.1. Market size and forecast, by component
9.2.3.6.3.2. Market size and forecast, by deployment mode
9.2.3.6.3.3. Market size and forecast, by end user
9.2.3.6.3.4. Market size and forecast, by application
9.2.3.6.3.5. Market size and forecast, by therapeutic area
9.3. Europe
9.3.1. Key market trends
9.3.2. Key growth factors and opportunities
9.3.3. Market size and forecast by
9.3.3.1. Component
9.3.3.2. Deployment mode
9.3.3.3. End user
9.3.3.4. Application
9.3.3.5. Therapeutic area
9.3.3.6. Country
9.3.3.6.1. UK
9.3.3.6.1.1. Market size and forecast, by component
9.3.3.6.1.2. Market size and forecast, by deployment mode
9.3.3.6.1.3. Market size and forecast, by end user
9.3.3.6.1.4. Market size and forecast, by application
9.3.3.6.1.5. Market size and forecast, by therapeutic area
9.3.3.6.2. Germany
9.3.3.6.2.1. Market size and forecast, by component
9.3.3.6.2.2. Market size and forecast, by deployment mode
9.3.3.6.2.3. Market size and forecast, by end user
9.3.3.6.2.4. Market size and forecast, by application
9.3.3.6.2.5. Market size and forecast, by therapeutic area
9.3.3.6.3. France
9.3.3.6.3.1. Market size and forecast, by component
9.3.3.6.3.2. Market size and forecast, by deployment mode
9.3.3.6.3.3. Market size and forecast, by end user
9.3.3.6.3.4. Market size and forecast, by application
9.3.3.6.3.5. Market size and forecast, by therapeutic area
9.3.3.6.4. Rest of Europe
9.3.3.6.4.1. Market size and forecast, by component
9.3.3.6.4.2. Market size and forecast, by deployment mode
9.3.3.6.4.3. Market size and forecast, by end user
9.3.3.6.4.4. Market size and forecast, by application
9.3.3.6.4.5. Market size and forecast, by therapeutic area
9.4. Asia-Pacific
9.4.1. Key market trends
9.4.2. Key growth factors and opportunities
9.4.3. Market size and forecast by
9.4.3.1. Component
9.4.3.2. Deployment mode
9.4.3.3. End user
9.4.3.4. Application
9.4.3.5. Therapeutic area
9.4.3.6. Country
9.4.3.6.1. China
9.4.3.6.1.1. Market size and forecast, by component
9.4.3.6.1.2. Market size and forecast, by deployment mode
9.4.3.6.1.3. Market size and forecast, by end user
9.4.3.6.1.4. Market size and forecast, by application
9.4.3.6.1.5. Market size and forecast, by therapeutic area
9.4.3.6.2. India
9.4.3.6.2.1. Market size and forecast, by component
9.4.3.6.2.2. Market size and forecast, by deployment mode
9.4.3.6.2.3. Market size and forecast, by end user
9.4.3.6.2.4. Market size and forecast, by application
9.4.3.6.2.5. Market size and forecast, by therapeutic area
9.4.3.6.3. Japan
9.4.3.6.3.1. Market size and forecast, by component
9.4.3.6.3.2. Market size and forecast, by deployment mode
9.4.3.6.3.3. Market size and forecast, by end user
9.4.3.6.3.4. Market size and forecast, by application
9.4.3.6.3.5. Market size and forecast, by therapeutic area
9.4.3.6.4. Rest of Asia-Pacific
9.4.3.6.4.1. Market size and forecast, by component
9.4.3.6.4.2. Market size and forecast, by deployment mode
9.4.3.6.4.3. Market size and forecast, by end user
9.4.3.6.4.4. Market size and forecast, by application
9.4.3.6.4.5. Market size and forecast, by therapeutic area
9.5. LAMEA
9.5.1. Key market trends
9.5.2. Key growth factors and opportunities
9.5.3. Market size and forecast by
9.5.3.1. Component
9.5.3.2. Deployment mode
9.5.3.3. End user
9.5.3.4. Application
9.5.3.5. Therapeutic area
9.5.3.6. Country
9.5.3.6.1. Latin America
9.5.3.6.1.1. Market size and forecast, by component
9.5.3.6.1.2. Market size and forecast, by deployment mode
9.5.3.6.1.3. Market size and forecast, by end user
9.5.3.6.1.4. Market size and forecast, by application
9.5.3.6.1.5. Market size and forecast, by therapeutic area
9.5.3.6.2. Middle East
9.5.3.6.2.1. Market size and forecast, by component
9.5.3.6.2.2. Market size and forecast, by deployment mode
9.5.3.6.2.3. Market size and forecast, by end user
9.5.3.6.2.4. Market size and forecast, by application
9.5.3.6.2.5. Market size and forecast, by therapeutic area
9.5.3.6.3. Africa
9.5.3.6.3.1. Market size and forecast, by component
9.5.3.6.3.2. Market size and forecast, by deployment mode
9.5.3.6.3.3. Market size and forecast, by end user
9.5.3.6.3.4. Market size and forecast, by application
9.5.3.6.3.5. Market size and forecast, by therapeutic area
10. COMPANY PROFILES
10.1. Cisco Systems, Inc.
10.1.1. Company overview
10.1.2. Company snapshot
10.1.3. Business performance
10.1.4. Operating business segments
10.1.5. Key strategies and developments
10.2. Mckesson Corporation
10.2.1. Company overview
10.2.2. Company snapshot
10.2.3. Business performance
10.2.4. Operating business segments
10.2.5. Key strategies and developments
10.3. Welvu, Inc.
10.3.1. Company overview
10.3.2. Company snapshot
10.3.3. Business performance
10.3.4. Operating business segments
10.3.5. Key strategies and developments
10.4. Get Real Health
10.4.1. Company overview
10.4.2. Company snapshot
10.4.3. Business performance
10.4.4. Operating business segments
10.4.5. Key strategies and developments
10.5. EMMI Solutions, LLC
10.5.1. Company overview
10.5.2. Company snapshot
10.5.3. Business performance
10.5.4. Operating business segments
10.5.5. Key strategies and developments
10.6. GetWellNetwork Inc
10.6.1. Company overview
10.6.2. Company snapshot
10.6.3. Business performance
10.6.4. Operating business segments
10.6.5. Key strategies and developments
10.7. Phytel, Inc.
10.7.1. Company overview
10.7.2. Company snapshot
10.7.3. Business performance
10.7.4. Operating business segments
10.7.5. Key strategies and developments
10.8. Mckesson Corporation
10.8.1. Company overview
10.8.2. Company snapshot
10.8.3. Business performance
10.8.4. Operating business segments
10.8.5. Key strategies and developments
10.9. Allscripts Healthcare Solutions
10.9.1. Company overview
10.9.2. Company snapshot
10.9.3. Business performance
10.9.4. Operating business segments
10.9.5. Key strategies and developments
10.10. Athenahealth, Inc.
10.10.1. Company overview
10.10.2. Company snapshot
10.10.3. Business performance
10.10.4. Operating business segments
10.10.5. Key strategies and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
